Lantern Pharma, Inc. (LTRN)
3.14
+0.01
(+0.32%)
USD |
NASDAQ |
May 15, 16:00
2.51
-0.63
(-20.06%)
After-Hours: 20:00
Lantern Pharma EPS Diluted (Quarterly) : -0.362 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioVie, Inc. | -0.6986 |
| Vertex Pharmaceuticals, Inc. | 4.024 |
| Spero Therapeutics, Inc. | -0.1258 |
| Replimune Group, Inc. | -0.7694 |
| Acurx Pharmaceuticals, Inc. | -0.6184 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.074M |
| Total Expenses (Quarterly) | 4.074M |
| Enterprise Value | 25.30M |
| Earnings Yield | -50.00% |
| Normalized Earnings Yield | -50.00 |